ux007
Showing 1 - 4 of 4
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Carnitine Palmitoyltransferase (CPT II) Deficiency, Very Long Chain
Completed
- Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
- +4 more
- UX007
-
Washington, District of Columbia
- +9 more
Jan 21, 2021
Glucose Transporter Type 1 Deficiency Syndrome Trial in Worldwide (UX007)
Terminated
- Glucose Transporter Type 1 Deficiency Syndrome
- UX007
-
Aurora, Colorado
- +8 more
Jun 3, 2020
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Trial in Worldwide (UX007, Placebo)
Terminated
- Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
- UX007
- Placebo
-
Aurora, Colorado
- +11 more
Jun 3, 2020
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Trial in Worldwide (UX007, Placebo)
Completed
- Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
- UX007
- Placebo
-
Aurora, Colorado
- +13 more
Jun 8, 2020